(19)
(11) EP 1 373 501 A2

(12)

(88) Date of publication A3:
09.10.2003

(43) Date of publication:
02.01.2004 Bulletin 2004/01

(21) Application number: 01986322.4

(22) Date of filing: 05.10.2001
(51) International Patent Classification (IPC)7C12N 15/12, C12N 15/62, C12N 15/86, C12N 15/47, C07K 14/705, A61K 48/00, G01N 33/50
(86) International application number:
PCT/EP2001/011514
(87) International publication number:
WO 2002/029072 (11.04.2002 Gazette 2002/15)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 06.10.2000 US 684552
06.10.2000 US 327562 P

(71) Applicants:
  • Novartis AG
    4056 Basel (CH)

    BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR 
  • Novartis Pharma AG
    1230 Vienna (AT)

    AT 

(72) Inventors:
  • KIM, Jin, Gwan
    Germantown, MD 20876 (US)
  • SMITH, Theodore
    Ijamsville, MD 21754 (US)
  • STEVENSON, Susan, C.
    Frederick, MD 21701 (US)
  • KALEKO, Michael
    Rockville, MD 20854 (US)

(74) Representative: Gros, Florent 
Novartis AG
4002 Basel
4002 Basel (CH)

   


(54) TARGETING MOLECULES FOR ADENOVIRAL VECTORS